Pharmahungary Group ^Company

Pharmahungary Group provides contract research with strong scientific support and offers early-stage novel technologies for out-licensing. Pharmahungary Group provides wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on but not limited to cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) metabolic diseases (diabetes, dyslipidemia, atherosclerosis, obesity, uremia, etc), renal, and inflammation indications with strong scientific support Clinical R&D services focusing on full management of clinical trials with Medical Devices, Advanced Therapeutic Medicinal Products, Investigator Initiated Trials, and clinical trials that need strong regulatory & scientific support with e.g. sensitive patient population The company manages internal R&D projects to develop new technologies for out-licensing and co-development in the fields of diagnosis and therapy of cardiovascular and metabolic disease